1. Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?

   • Lindsey R. Fauveau
   • Tuoc N. Dao
   • Michael D. Grant

   Editorial 07 April 2023 Pages: 215 - 220

   

2. Contrast enhanced mammography in breast cancer surveillance

   • Kenneth Elder
   • Julia Matheson
   • Gregory Bruce Mann

   Preclinical study Open access 25 March 2023 Pages: 221 - 230

   

3. Phase III study of long-term prognosis of estrogen receptor-positive early breast cancer treated with neoadjuvant endocrine therapy with/without adjuvant chemotherapy

   • Hiroji Iwata
   • Yutaka Yamamoto
   • Takuhiro Yamaguchi

   Clinical trial Open access 22 March 2023 Pages: 231 - 241

   

4. Long-term outcomes of dual vs single HER2-directed neoadjuvant therapy in NSABP B-41

   • Priya Rastogi
   • Gong Tang
   • Norman Wolmark

   Clinical trial 22 March 2023 Pages: 243 - 252

   

5. Fulvestrant plus palbociclib in advanced or metastatic hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer after fulvestrant monotherapy: Japan Breast Cancer Research Group-M07 (FUTURE trial)

   • Kenichi Watanabe
   • Naoki Niikura
   • Shigehira Saji

   Clinical trial Open access 31 March 2023 Pages: 253 - 263

   

6. Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study

   • Rajiv V. Dave
   • Beatrix Elsberger
   • B-MaP-C study collaborative

   Clinical trial Open access 03 April 2023 Pages: 265 - 279

   

7. Association of baseline ROR1 and ROR2 gene expression with clinical outcomes in the I-SPY2 neoadjuvant breast cancer trial

   • Barbara A. Parker
   • Rebecca A. Shatsky
   • Thomas J. Kipps

   Clinical trial Open access 08 April 2023 Pages: 281 - 291

   

8. Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists

   • Carl Sars
   • Helena Sackey
   • Ebba K. Lindqvist

   Epidemiology Open access 06 March 2023 Pages: 293 - 304

9. Impact of diabetes on surgery and radiotherapy for breast cancer

   • Ross Lawrenson
   • Chunhuan Lao
   • Jason Gurney

   Epidemiology Open access 30 March 2023 Pages: 305 - 314

10. Cholesterol and breast cancer risk: a cohort study using health insurance claims and health checkup databases

    • Nobuhiro Narii
    • Ling Zha
    • Toshio Ogawa

    Epidemiology Open access 30 March 2023 Pages: 315 - 322

11. Hypertensive conditions of pregnancy, preterm birth, and premenopausal breast cancer risk: a premenopausal breast cancer collaborative group analysis

    • Hazel B. Nichols
    • Melissa G. House
    • Minouk J. Schoemaker

    Epidemiology 05 April 2023 Pages: 323 - 334

    

12. Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer

    • Christopher Godina
    • Helga Tryggvadottir
    • Helena Jernström

    Epidemiology Open access 05 April 2023 Pages: 335 - 347

    

13. HER-2 low status in early-stage invasive lobular carcinoma of the breast: associated factors and outcomes in an institutional series

    • Harriet T. Rothschild
    • Elle Clelland
    • Rita A. Mukhtar

    Epidemiology Open access 05 April 2023 Pages: 349 - 354

14. Metaplastic carcinoma of the breast: matched cohort analysis of recurrence and survival

    • Priyanka Narayan
    • Caroline E. Kostrzewa
    • Lior Z. Braunstein

    Brief Communication 28 March 2023 Pages: 355 - 361

    

15. Access disparities and underutilization of germline genetic testing in Chilean breast cancer patients

    • Francisco Acevedo
    • Benjamín Walbaum
    • César Sánchez

    Brief Communication 29 March 2023 Pages: 363 - 370

    

16. Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials

    • Elie Rassy
    • Thomas Filleron
    • Barbara Pistilli

    Brief Communication 29 March 2023 Pages: 371 - 379

    

17. Aspirin use is associated with improvement in distant metastases outcome in patients with residual disease after neoadjuvant chemotherapy

    • Christopher Johns
    • Steven K. Montalvo
    • D. W. Nathan Kim

    Brief Communication 30 March 2023 Pages: 381 - 387

    

18. Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis

    • Joyce M. Cheng
    • Jenna Canzoniero
    • Cesar A. Santa-Maria

    Brief Communication 31 March 2023 Pages: 389 - 397

    

19. Pharmacogenetics: uncovering the complex relationship between HIV and non-adherence among South African breast cancer patients treated with tamoxifen

    • Keneuoe C. Nthontho
    • Leabaneng Tawe
    • Giacomo M. Paganotti

    Letter to the Editor 30 March 2023 Pages: 399 - 400

20. Tumour Infiltrating Lymphocytes (TILs) and immune composition in breast cancer patients from Kenya: Spatial distributions and associations with risk factors and tumour characteristics

    • Shahin Sayed
    • Hela Koka
    • Dhirendra Govender

    Original Laboratory Investigation 03 April 2023 Pages: 401 - 413